NCT06103773View on ClinicalTrials.gov

A Study of Single and Multiple Oral Doses of TollB-001

PHASE1RecruitingINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

June 9, 2024

Study Completion Date

June 9, 2024

Conditions

Rheumatoid Arthritis

Interventions

DRUG

TollB-001 tablets

TollB-001 treatment

DRUG

TollB-001 placebo

TollB-001 Placebo

Trial Locations (1)

611130

RECRUITING

Chengdu Fifth People's Hospital, Chengdu

All Listed Sponsors

lead

Toll Biotech Co. Ltd. (Beijing)

INDUSTRY